Plasma Apolipoproteins A1/B and OxLDL Levels in Patients with Covid-19 As Possible Markers of the Disease
The COVID-19 infection is associated with dyslipidemia and cardiovascular complications. The aim of the study was to determine the content of ApoA1, ApoB, and oxidized low-density lipoproteins (oxLDL) in the plasma of patients ( n = 81) with COVID-19, diabetes, and cardiovascular disease (CVD). ApoA...
Saved in:
| Published in | Cytology and genetics Vol. 55; no. 6; pp. 519 - 523 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Moscow
Pleiades Publishing
2021
Springer Nature B.V |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The COVID-19 infection is associated with dyslipidemia and cardiovascular complications. The aim of the study was to determine the content of ApoA1, ApoB, and oxidized low-density lipoproteins (oxLDL) in the plasma of patients (
n
= 81) with COVID-19, diabetes, and cardiovascular disease (CVD). ApoA1, ApoB, and oxLDL were determined using enzyme-linked immunosorbent assay kits (Elabscience, United States). The measurements were performed at an optical wavelength of 450 nm. It was shown that the level of ApoA1 in the blood of patients with type 2 diabetes and especially with COVID-19 was significantly lower than in the blood of healthy people. Blood ApoA1 levels did not show a further decrease in patients with both COVID-19 and diabetes or CVD compared to patients with COVID-19 without concomitant diseases. It was found that the level of ApoB in the blood of patients with diabetes and, especially, with COVID-19 is significantly higher than in the blood of healthy people. Blood levels of ApoB and oxLDL are higher in patients with both COVID-19 and diabetes or CVD compared to patients with COVID-19 without comorbidities. Thus, levels of ApoA1, ApoB, and oxLDL may be promising markers of COVID-19. |
|---|---|
| AbstractList | The COVID-19 infection is associated with dyslipidemia and cardiovascular complications. The aim of the study was to determine the content of ApoA1, ApoB, and oxidized low-density lipoproteins (oxLDL) in the plasma of patients (
n
= 81) with COVID-19, diabetes, and cardiovascular disease (CVD). ApoA1, ApoB, and oxLDL were determined using enzyme-linked immunosorbent assay kits (Elabscience, United States). The measurements were performed at an optical wavelength of 450 nm. It was shown that the level of ApoA1 in the blood of patients with type 2 diabetes and especially with COVID-19 was significantly lower than in the blood of healthy people. Blood ApoA1 levels did not show a further decrease in patients with both COVID-19 and diabetes or CVD compared to patients with COVID-19 without concomitant diseases. It was found that the level of ApoB in the blood of patients with diabetes and, especially, with COVID-19 is significantly higher than in the blood of healthy people. Blood levels of ApoB and oxLDL are higher in patients with both COVID-19 and diabetes or CVD compared to patients with COVID-19 without comorbidities. Thus, levels of ApoA1, ApoB, and oxLDL may be promising markers of COVID-19. The COVID-19 infection is associated with dyslipidemia and cardiovascular complications. The aim of the study was to determine the content of ApoA1, ApoB, and oxidized low-density lipoproteins (oxLDL) in the plasma of patients (n = 81) with COVID-19, diabetes, and cardiovascular disease (CVD). ApoA1, ApoB, and oxLDL were determined using enzyme-linked immunosorbent assay kits (Elabscience, United States). The measurements were performed at an optical wavelength of 450 nm. It was shown that the level of ApoA1 in the blood of patients with type 2 diabetes and especially with COVID-19 was significantly lower than in the blood of healthy people. Blood ApoA1 levels did not show a further decrease in patients with both COVID-19 and diabetes or CVD compared to patients with COVID-19 without concomitant diseases. It was found that the level of ApoB in the blood of patients with diabetes and, especially, with COVID-19 is significantly higher than in the blood of healthy people. Blood levels of ApoB and oxLDL are higher in patients with both COVID-19 and diabetes or CVD compared to patients with COVID-19 without comorbidities. Thus, levels of ApoA1, ApoB, and oxLDL may be promising markers of COVID-19. The COVID-19 infection is associated with dyslipidemia and cardiovascular complications. The aim of the study was to determine the content of ApoA1, ApoB, and oxidized low-density lipoproteins (oxLDL) in the plasma of patients ( = 81) with COVID-19, diabetes, and cardiovascular disease (CVD). ApoA1, ApoB, and oxLDL were determined using enzyme-linked immunosorbent assay kits (Elabscience, United States). The measurements were performed at an optical wavelength of 450 nm. It was shown that the level of ApoA1 in the blood of patients with type 2 diabetes and especially with COVID-19 was significantly lower than in the blood of healthy people. Blood ApoA1 levels did not show a further decrease in patients with both COVID-19 and diabetes or CVD compared to patients with COVID-19 without concomitant diseases. It was found that the level of ApoB in the blood of patients with diabetes and, especially, with COVID-19 is significantly higher than in the blood of healthy people. Blood levels of ApoB and oxLDL are higher in patients with both COVID-19 and diabetes or CVD compared to patients with COVID-19 without comorbidities. Thus, levels of ApoA1, ApoB, and oxLDL may be promising markers of COVID-19. |
| Author | Belchina, Yu. B. Sokolova, L. K. Kovzun, O. I. Pushkarev, V. V. Chervyakova, S. A. Tronko, M. D. Pushkarev, V. M. |
| Author_xml | – sequence: 1 givenname: V. V. surname: Pushkarev fullname: Pushkarev, V. V. email: pushkarev.vm@gmail.com organization: SI “V.P. Komisarenko Institute of Endocrinology and Metabolism, National Academy of Medical Sciences of Ukraine” – sequence: 2 givenname: L. K. surname: Sokolova fullname: Sokolova, L. K. email: liubov_sokolova@ukr.net organization: SI “V.P. Komisarenko Institute of Endocrinology and Metabolism, National Academy of Medical Sciences of Ukraine” – sequence: 3 givenname: S. A. surname: Chervyakova fullname: Chervyakova, S. A. email: svitlana.cherviakova@gmail.com organization: SI “V.P. Komisarenko Institute of Endocrinology and Metabolism, National Academy of Medical Sciences of Ukraine” – sequence: 4 givenname: Yu. B. surname: Belchina fullname: Belchina, Yu. B. email: belchina_@ukr.net organization: SI “V.P. Komisarenko Institute of Endocrinology and Metabolism, National Academy of Medical Sciences of Ukraine” – sequence: 5 givenname: O. I. surname: Kovzun fullname: Kovzun, O. I. email: kovzun.oi@gmail.com organization: SI “V.P. Komisarenko Institute of Endocrinology and Metabolism, National Academy of Medical Sciences of Ukraine” – sequence: 6 givenname: V. M. surname: Pushkarev fullname: Pushkarev, V. M. email: endocrinology.kiev@gmail.com organization: SI “V.P. Komisarenko Institute of Endocrinology and Metabolism, National Academy of Medical Sciences of Ukraine” – sequence: 7 givenname: M. D. surname: Tronko fullname: Tronko, M. D. email: axolotle@gmail.com organization: SI “V.P. Komisarenko Institute of Endocrinology and Metabolism, National Academy of Medical Sciences of Ukraine” |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34898734$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kUtv1DAUhS3Uik5LfwAbZIkNm1C_k2yQhimFSkEdqd1bjnPTccnYwc5My7-vR1PKS6zu4nz33Mc5Rgc-eEDoNSXvOSX87JqQWgrJSkaJIpSqF2hGay6KWghygGY7udjpR-g4pTtCpGKcv0RHXFR1VXIxQ245mLQ2eD6GwY1hjGEC5xOe07OP2PgOXz005w1uYAtDws7jpZkc-Cnhezet8CJsXVfQGs8TXoaUXDsA_mriN4gJhx5PK8DnLoFJ8Aod9mZIcPpUT9DNxaebxZeiufp8uZg3hRUlmYqOAQUhibRQC1pWpiyVsEaorqWdoC2wvjKit30lM2i4ZaIVWbZU1n3X8RP0YW87bto1dDbvGs2gx-jWJv7QwTj9p-LdSt-Gra5U_hRj2eDdk0EM3zeQJr12ycIwGA9hkzRTlJBKKqoy-vYv9C5sos_XZYoIUXEmZabonrIxfyhC_7wMJXqXo_4nx9zz5vcrnjt-BpcBtgdSlvwtxF-j_-_6CBsRqJ4 |
| CitedBy_id | crossref_primary_10_31793_1680_1466_2022_27_3_271 crossref_primary_10_31793_1680_1466_2023_28_1_5 crossref_primary_10_1242_dmm_049572 crossref_primary_10_1186_s12014_023_09394_0 crossref_primary_10_3390_biomedicines10030699 crossref_primary_10_31793_1680_1466_2022_27_4_359 crossref_primary_10_31793_1680_1466_2022_27_2_106 |
| Cites_doi | 10.3389/fimmu.2020.00024 10.1016/j.jacl.2020.04.008 10.1161/ATVBAHA.119.313195 10.1097/M0L.0000000000000253 10.22141/2224-0721.13.7.2017.115747 10.1155/2020/5245308 10.1016/j.jlr.2021.100067 10.1038/s41598-021-81638-1 10.1016/j.bbalip.2020.158849 10.1007/s11011-015-9732-7 10.1186/s12902-021-00726-5 10.1016/j.jacl.2020.07.004 10.1002/iid3.355 10.1001/jamacardio.2019.3780 10.1016/j.molmet.2020.01.013 10.1097/MD.0000000000005834 10.3390/cells10040850 10.21203/rs.3.rs-31251/v1 |
| ContentType | Journal Article |
| Copyright | Allerton Press, Inc. 2021. ISSN 0095-4527, Cytology and Genetics, 2021, Vol. 55, No. 6, pp. 519–523. © Allerton Press, Inc., 2021. Ukrainian Text © The Author(s), 2021, published in Tsitologiya i Genetika, 2021, Vol. 55, No. 6, pp. 26–31. Allerton Press, Inc. 2021, ISSN 0095-4527, Cytology and Genetics, 2021, Vol. 55, No. 6, pp. 519–523. © Allerton Press, Inc., 2021.Ukrainian Text © The Author(s), 2021, published in Tsitologiya i Genetika, 2021, Vol. 55, No. 6, pp. 26–31. |
| Copyright_xml | – notice: Allerton Press, Inc. 2021. ISSN 0095-4527, Cytology and Genetics, 2021, Vol. 55, No. 6, pp. 519–523. © Allerton Press, Inc., 2021. Ukrainian Text © The Author(s), 2021, published in Tsitologiya i Genetika, 2021, Vol. 55, No. 6, pp. 26–31. – notice: Allerton Press, Inc. 2021, ISSN 0095-4527, Cytology and Genetics, 2021, Vol. 55, No. 6, pp. 519–523. © Allerton Press, Inc., 2021.Ukrainian Text © The Author(s), 2021, published in Tsitologiya i Genetika, 2021, Vol. 55, No. 6, pp. 26–31. |
| DBID | NPM AAYXX CITATION 7X8 5PM |
| DOI | 10.3103/S0095452721060116 |
| DatabaseName | PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
| DatabaseTitleList | PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1934-9440 |
| EndPage | 523 |
| ExternalDocumentID | 10_3103_S0095452721060116 34898734 |
| Genre | Journal Article |
| GroupedDBID | -56 -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 1N0 29F 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 4.4 408 40D 40E 5GY 5VS 67N 6NX 8TC 95- 95. 95~ 96X AABHQ AAFGU AAHNG AAIAL AAJKR AANXM AANZL AAPBV AARHV AARTL AATNV AATVU AAUYE AAWCG AAYFA AAYIU AAYQN AAYTO ABDZT ABECU ABFGW ABFTV ABHQN ABJNI ABJOX ABKAS ABKCH ABMNI ABMQK ABNWP ABQBU ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABWNU ABXPI ACBMV ACBRV ACBYP ACCUX ACGFS ACHSB ACHXU ACIGE ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACSNA ACTTH ACVWB ACWMK ADHHG ADHIR ADINQ ADKNI ADMDM ADOXG ADRFC ADURQ ADYFF ADZKW AEBTG AEFTE AEGAL AEGNC AEJHL AEJRE AENEX AEOHA AEPYU AESTI AETLH AEVLU AEVTX AEXYK AFGCZ AFLOW AFNRJ AFQWF AFWTZ AFZKB AGAYW AGDGC AGGBP AGJBK AGMZJ AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHSBF AI. AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ AXYYD B-. BA0 BDATZ BGNMA CAG COF CS3 DDRTE DNIVK DPUIP DU5 EBLON EBS EIOEI EJD EN4 ESBYG FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 HF~ HG6 HLICF HMJXF HRMNR HZ~ IJ- IKXTQ IWAJR I~X I~Z J-C JBSCW JZLTJ KOV KPH LLZTM M4Y MA- N9A NPVJJ NQJWS NU0 O9- O93 O9I O9J PF0 PT4 QOR QOS R89 R9I RNS ROL RPX RSV S16 S1Z S27 S3A S3B SAP SBL SDH SHX SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW STPWE SZN T13 TSG TUC U2A U9L UG4 UNUBA UOJIU UTJUX UZXMN VC2 VFIZW VH1 W48 WK8 XU3 YLTOR ZMTXR ZOVNA ~A9 AACDK AAHBH AAJBT AASML AAYZH ABAKF ACAOD ACDTI ACZOJ AEFQL AEMSY AFBBN AGRTI AIGIU H13 NPM SJYHP AAYXX CITATION 7X8 5PM |
| ID | FETCH-LOGICAL-c470t-d2e1e4505ce94178a7764ca46db1d41be2f8a4fcf85e1ea3c24b4a46c159fdd3 |
| IEDL.DBID | AGYKE |
| ISSN | 0095-4527 |
| IngestDate | Tue Sep 17 21:28:44 EDT 2024 Fri Aug 16 08:04:55 EDT 2024 Thu Oct 10 19:03:55 EDT 2024 Thu Sep 12 18:41:35 EDT 2024 Wed Oct 16 00:43:14 EDT 2024 Sat Dec 16 12:08:15 EST 2023 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | COVID-19 oxLDL diabetes mellitus cardiovascular diseases apolipoprotein A1 apolipoprotein B |
| Language | English |
| License | Allerton Press, Inc. 2021, ISSN 0095-4527, Cytology and Genetics, 2021, Vol. 55, No. 6, pp. 519–523. © Allerton Press, Inc., 2021.Ukrainian Text © The Author(s), 2021, published in Tsitologiya i Genetika, 2021, Vol. 55, No. 6, pp. 26–31. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c470t-d2e1e4505ce94178a7764ca46db1d41be2f8a4fcf85e1ea3c24b4a46c159fdd3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC8645222 |
| PMID | 34898734 |
| PQID | 2604483255 |
| PQPubID | 2043936 |
| PageCount | 5 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8645222 proquest_miscellaneous_2610085616 proquest_journals_2604483255 crossref_primary_10_3103_S0095452721060116 pubmed_primary_34898734 springer_journals_10_3103_S0095452721060116 |
| PublicationCentury | 2000 |
| PublicationDate | 11-2021 |
| PublicationDateYYYYMMDD | 2021-01-01 |
| PublicationDate_xml | – year: 2021 text: 11-2021 |
| PublicationDecade | 2020 |
| PublicationPlace | Moscow |
| PublicationPlace_xml | – name: Moscow – name: United States – name: New York |
| PublicationTitle | Cytology and genetics |
| PublicationTitleAbbrev | Cytol. Genet |
| PublicationTitleAlternate | Cytol Genet |
| PublicationYear | 2021 |
| Publisher | Pleiades Publishing Springer Nature B.V |
| Publisher_xml | – name: Pleiades Publishing – name: Springer Nature B.V |
| References | Kocar, Rezen, Rozman (CR11) 2021; 1866 Yan, Song, Wu, Wang (CR19) 2020; 11 Sniderman, Thanassoulis, Glavinovic (CR15) 2019; 4 Mao, Xu, Lu (CR12) 2017; 96 Rye, Barter, Cochran (CR14) 2016; 27 Dong, Chen, Wang (CR4) 2015; 30 Wei, Zeng, Su (CR18) 2020; 14 CR17 Feingold (CR5) 2021; 62 Retnakaran, Ye, Connelly (CR13) 2019; 39 Begue, Tanaka, Mouktadi (CR1) 2021; 11 Fogacci, Borghi, Cicero (CR6) 2020; 14 Inoue, Okamoto, Honda (CR9) 2020; 8 CR20 Cochran, Ong, Manandhar, Rye (CR2) 2021; 10 Devaraj, Semaan, Jialal (CR3) 2020 Sokolova, Pushkarev, Pushkarev (CR16) 2017; 13 Fritzen, Domingo-Espin, Lundsgaard (CR7) 2020; 35 Gao, Zhang, Wang, Dong (CR8) 2021; 21 Khatana, Saini, Chakrabarti (CR10) 2020; 2020 Zamanian, Arjmand, Zali, Razzaghi (CR21) 2020; 13 S. Devaraj (7215_CR3) 2020 B.J. Cochran (7215_CR2) 2021; 10 Y. Yan (7215_CR19) 2020; 11 C. Khatana (7215_CR10) 2020; 2020 K.R. Feingold (7215_CR5) 2021; 62 F. Fogacci (7215_CR6) 2020; 14 7215_CR20 X. Wei (7215_CR18) 2020; 14 F. Begue (7215_CR1) 2021; 11 E. Kocar (7215_CR11) 2021; 1866 Y. Inoue (7215_CR9) 2020; 8 H. Dong (7215_CR4) 2015; 30 A.M. Fritzen (7215_CR7) 2020; 35 L. Sokolova (7215_CR16) 2017; 13 L. Gao (7215_CR8) 2021; 21 Y. Mao (7215_CR12) 2017; 96 K.A. Rye (7215_CR14) 2016; 27 A.D. Sniderman (7215_CR15) 2019; 4 A.M. Zamanian (7215_CR21) 2020; 13 R. Retnakaran (7215_CR13) 2019; 39 7215_CR17 |
| References_xml | – volume: 11 start-page: 24 year: 2020 ident: CR19 article-title: Long noncoding RNAs link oxidized low-density lipoprotein with the inflammatory response of macrophages in atherogenesis publication-title: Front. Immunol doi: 10.3389/fimmu.2020.00024 contributor: fullname: Wang – volume: 14 start-page: 297 year: 2020 end-page: 304 ident: CR18 article-title: Hypolipidemia is associated with the severity of COVID-19 publication-title: J. Clin. Lipidol doi: 10.1016/j.jacl.2020.04.008 contributor: fullname: Su – volume: 39 start-page: 2192 year: 2019 end-page: 2197 ident: CR13 article-title: Serum apoAl (apolipoprotein A-1), insulin resistance, and the risk of gestational diabetes mellitus in human pregnancy—brief report publication-title: Arterioscler. Thromb. Vasc. Biol doi: 10.1161/ATVBAHA.119.313195 contributor: fullname: Connelly – volume: 27 start-page: 8 year: 2016 end-page: 13 ident: CR14 article-title: Apolipoprotein A-I interactions with insulin secretion and production publication-title: Curr. Opin. Lipidol. doi: 10.1097/M0L.0000000000000253 contributor: fullname: Cochran – year: 2020 ident: CR3 contributor: fullname: Jialal – volume: 13 start-page: 486 year: 2017 end-page: 498 ident: CR16 article-title: Diabetes mellitus and atherosclerosis. The role of inflammatory processes in pathogenesis publication-title: Int. J. Endocrinol. (Ukraine) doi: 10.22141/2224-0721.13.7.2017.115747 contributor: fullname: Pushkarev – volume: 2020 start-page: 5245308 year: 2020 ident: CR10 article-title: Mechanistic insights into the oxidized low-density lipoprotein-induced atherosclerosis publication-title: Oxid. Med. Cell Longev doi: 10.1155/2020/5245308 contributor: fullname: Chakrabarti – ident: CR17 – volume: 62 start-page: 100067 year: 2021 ident: CR5 article-title: The bidirectional link between HDL and COVID-19 infections publication-title: J. Lipid Res doi: 10.1016/j.jlr.2021.100067 contributor: fullname: Feingold – volume: 11 start-page: 2291 year: 2021 ident: CR1 article-title: Altered high-density lipoprotein composition and functions during severe COVID-19 publication-title: Sci. Rep doi: 10.1038/s41598-021-81638-1 contributor: fullname: Mouktadi – volume: 1866 start-page: 158849 year: 2021 ident: CR11 article-title: Cholesterol, lipoproteins, and COVID-19: basic concepts and clinical applications publication-title: Biochim. Biophys. Acta Mol. Cell Biol. Lipids doi: 10.1016/j.bbalip.2020.158849 contributor: fullname: Rozman – volume: 30 start-page: 1319 year: 2015 end-page: 1330 ident: CR4 article-title: Apolipoprotein A1, B levels, and their ratio and the risk of a first stroke: a meta-analysis and case-control study publication-title: Metab. Brain Dis doi: 10.1007/s11011-015-9732-7 contributor: fullname: Wang – volume: 21 start-page: 59 year: 2021 ident: CR8 article-title: Association of apolipoproteins A1 and B with type 2 diabetes and fasting blood glucose: a cross-sectional study publication-title: BMC Endocrinol. Disord doi: 10.1186/s12902-021-00726-5 contributor: fullname: Dong – volume: 14 start-page: 543 year: 2020 end-page: 544 ident: CR6 article-title: Misinterpreting data in lipidology in the era of COVID-19 publication-title: J. Clin. Lipidol doi: 10.1016/j.jacl.2020.07.004 contributor: fullname: Cicero – volume: 8 start-page: 659 year: 2020 end-page: 671 ident: CR9 article-title: Disruption in the balance between apolipoprotein A-I and mast cell chymase in chronic hypersensitivity pneumonitis publication-title: Immun. Inflamm. Dis doi: 10.1002/iid3.355 contributor: fullname: Honda – volume: 4 start-page: 1287 year: 2019 end-page: 1295 ident: CR15 article-title: Apolipoprotein B particles and cardiovascular disease: a narrative review publication-title: JAMA Cardiol doi: 10.1001/jamacardio.2019.3780 contributor: fullname: Glavinovic – volume: 35 start-page: 100949 year: 2020 ident: CR7 article-title: ApoA-1 improves glucose tolerance by increasing glucose uptake into heart and skeletal muscle independently of AMPKa2 publication-title: Mol. Metab doi: 10.1016/j.molmet.2020.01.013 contributor: fullname: Lundsgaard – volume: 96 start-page: e5834 year: 2017 ident: CR12 article-title: The nonlinear association between apolipoprotein B to apolipoprotein A1 ratio and type 2 diabetes publication-title: Medicine doi: 10.1097/MD.0000000000005834 contributor: fullname: Lu – volume: 10 start-page: 850 year: 2021 ident: CR2 article-title: High density lipoproteins and diabetes publication-title: Cells doi: 10.3390/cells10040850 contributor: fullname: Rye – ident: CR20 – volume: 13 start-page: 367 year: 2020 end-page: 373 ident: CR21 article-title: Introducing AP0A1 as a key protein in COVID-19 infection: a bioinformatics approach publication-title: Gastroenterol. Hepatol. Bed Bench contributor: fullname: Razzaghi – volume: 10 start-page: 850 year: 2021 ident: 7215_CR2 publication-title: Cells doi: 10.3390/cells10040850 contributor: fullname: B.J. Cochran – volume: 13 start-page: 486 year: 2017 ident: 7215_CR16 publication-title: Int. J. Endocrinol. (Ukraine) doi: 10.22141/2224-0721.13.7.2017.115747 contributor: fullname: L. Sokolova – volume: 96 start-page: e5834 year: 2017 ident: 7215_CR12 publication-title: Medicine doi: 10.1097/MD.0000000000005834 contributor: fullname: Y. Mao – volume: 27 start-page: 8 year: 2016 ident: 7215_CR14 publication-title: Curr. Opin. Lipidol. doi: 10.1097/M0L.0000000000000253 contributor: fullname: K.A. Rye – volume: 14 start-page: 297 year: 2020 ident: 7215_CR18 publication-title: J. Clin. Lipidol doi: 10.1016/j.jacl.2020.04.008 contributor: fullname: X. Wei – volume: 35 start-page: 100949 year: 2020 ident: 7215_CR7 publication-title: Mol. Metab doi: 10.1016/j.molmet.2020.01.013 contributor: fullname: A.M. Fritzen – volume: 4 start-page: 1287 year: 2019 ident: 7215_CR15 publication-title: JAMA Cardiol doi: 10.1001/jamacardio.2019.3780 contributor: fullname: A.D. Sniderman – volume: 2020 start-page: 5245308 year: 2020 ident: 7215_CR10 publication-title: Oxid. Med. Cell Longev doi: 10.1155/2020/5245308 contributor: fullname: C. Khatana – volume: 8 start-page: 659 year: 2020 ident: 7215_CR9 publication-title: Immun. Inflamm. Dis doi: 10.1002/iid3.355 contributor: fullname: Y. Inoue – volume: 11 start-page: 2291 year: 2021 ident: 7215_CR1 publication-title: Sci. Rep doi: 10.1038/s41598-021-81638-1 contributor: fullname: F. Begue – volume: 14 start-page: 543 year: 2020 ident: 7215_CR6 publication-title: J. Clin. Lipidol doi: 10.1016/j.jacl.2020.07.004 contributor: fullname: F. Fogacci – volume: 11 start-page: 24 year: 2020 ident: 7215_CR19 publication-title: Front. Immunol doi: 10.3389/fimmu.2020.00024 contributor: fullname: Y. Yan – ident: 7215_CR20 doi: 10.21203/rs.3.rs-31251/v1 – volume: 39 start-page: 2192 year: 2019 ident: 7215_CR13 publication-title: Arterioscler. Thromb. Vasc. Biol doi: 10.1161/ATVBAHA.119.313195 contributor: fullname: R. Retnakaran – volume: 62 start-page: 100067 year: 2021 ident: 7215_CR5 publication-title: J. Lipid Res doi: 10.1016/j.jlr.2021.100067 contributor: fullname: K.R. Feingold – volume: 21 start-page: 59 year: 2021 ident: 7215_CR8 publication-title: BMC Endocrinol. Disord doi: 10.1186/s12902-021-00726-5 contributor: fullname: L. Gao – volume: 30 start-page: 1319 year: 2015 ident: 7215_CR4 publication-title: Metab. Brain Dis doi: 10.1007/s11011-015-9732-7 contributor: fullname: H. Dong – volume-title: StatPearls year: 2020 ident: 7215_CR3 contributor: fullname: S. Devaraj – volume: 1866 start-page: 158849 year: 2021 ident: 7215_CR11 publication-title: Biochim. Biophys. Acta Mol. Cell Biol. Lipids doi: 10.1016/j.bbalip.2020.158849 contributor: fullname: E. Kocar – volume: 13 start-page: 367 year: 2020 ident: 7215_CR21 publication-title: Gastroenterol. Hepatol. Bed Bench contributor: fullname: A.M. Zamanian – ident: 7215_CR17 |
| SSID | ssj0056233 |
| Score | 2.2742229 |
| Snippet | The COVID-19 infection is associated with dyslipidemia and cardiovascular complications. The aim of the study was to determine the content of ApoA1, ApoB, and... |
| SourceID | pubmedcentral proquest crossref pubmed springer |
| SourceType | Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | 519 |
| SubjectTerms | Apolipoproteins Biomedical and Life Sciences Biomedicine Blood levels Cardiovascular diseases Coronaviruses COVID-19 Diabetes Diabetes mellitus (non-insulin dependent) Dyslipidemia Enzyme-linked immunosorbent assay Human Genetics Lipoproteins |
| Title | Plasma Apolipoproteins A1/B and OxLDL Levels in Patients with Covid-19 As Possible Markers of the Disease |
| URI | https://link.springer.com/article/10.3103/S0095452721060116 https://www.ncbi.nlm.nih.gov/pubmed/34898734 https://www.proquest.com/docview/2604483255 https://search.proquest.com/docview/2610085616 https://pubmed.ncbi.nlm.nih.gov/PMC8645222 |
| Volume | 55 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB61WyFxoVBeC6UapJ5AWTaO8zqGPqhgW_bQSuUUOY4tVgWnIrtS21_PTB6LloVDz544tsf2fOOxvwHYJ9AmyAzF3lhY4UkyAh4ZYc2nTeT7RKIomzSdp2fRyYX8fBleboBYHl24q1EfkWw26satHAf8pDflfNjksTCFiB9twlbIfF8D2Mo-ffty1O-_bNA77snQ4w_aWOa_K1m1RmsQc_2m5F_h0sYKHW-3LwPrhryQL59cjRbzYqTv1qkd79HBx_CoA6WYtbPoCWwYtwMP2jSVt09hNiWI_VNhxhkdrquG2mHmasz8Dx9RuRK_3kwOJzjh-0c1zhxOW7LWGvmUFw_4rZ_np5jVOK14Df4wyG-ECHliZZEgKB62caJncH58dH5w4nUpGjwt4_HcK4XxjSQUpU0q_ThRcRxJrWRUFn4p_cIImyhptU1CElSBFrKQVKwJRdmyDJ7DwFXOvAQslOYI4NiGkZJhXKSyNMpSxakVQkdyCO96TeXXLRFHTg4MD12-NnRD2O11mXdrss7JcyNfNCAfaghvl8W0mjhEopypFizDZEeEKamKF63ql38LZJImcUAtiVcmxVKAmbpXS9zse8PYnXD4WIghvO9V_6dZ_-3Eq3tJv4aHgq_bNKdDuzCY_1qYN4SX5sVet0D2YPNCZL8Bv2UImg |
| link.rule.ids | 230,315,786,790,891,27955,27956,41114,41556,42183,42625,52144,52267 |
| linkProvider | Springer Nature |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9NAEB5BqgouvFogUGCQeipyidfr19H0QaBum0MqtSdrvd4VEWBXOJGAX8-MH0Fp4NDzrtf7nm92Zr4B2CXQJkgMhc5IWOFIEgIOCWHNr02k-wQiL5o0nadnwfhCfr70L7s47rr3du9Nks1N3eiVI49jemNOiE0qC3OIuMFd2JAs4AewkXy8OjnqL2CW6B35pO_wB60x89-NrIqjNYy57ip5w17aiKHjhzDtB9B6n3zdX8zzff37BrfjLUf4CB50sBSTdh89hjumfAKbbaLKX1swmxDI_q4w4ZwO11VD7jAra0zc9x9QlQWe_0wPU0zZA6nGWYmTlq61Rn7nxQOO9nPcGJMaJxWfwm8GOUqIsCdWFgmE4mFrKdqG6fHR9GDsdEkaHC3D0dwphHGNJBylTSzdMFJhGEitZFDkbiHd3AgbKWm1jXyqqDwtZC6pWBOOskXhPYVBWZXmOWCuNNsAR9YPlPTDPJaFUZYajq0QOpBD2OuXKrtuqTgyUmF46rK1qRvCTr-YWXcq64x0N9JGPdKihvB2WUzniY0kqjTVgusw3RGhSmriWbv2y795Moqj0KOehCu7YlmBubpXS8rZl4azO2IDshBDeNcv_d9u_XcQL25V-w3cG09P0yz9dHbyEu4Ldr5p3op2YDD_sTCvCD3N89fdafkDGr0LhQ |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwEB5BVyAuvB-FBYzECZRt4zivY9huWdiy9LBIyynrOLaodnEqkkrAr2cmToq6hQPibMeJH5P5xjPzDcBLBG0c1VDsjbnhnkAl4KESVnTbhLZPxIuyLdP54Tg6_CTen4anXZ3Tuo92712SLqeBWJpsM1qWZtTamOOA8ntTKo6N5gvxifjRVdgRKLViADvZ289HB_3PmLR7R0QZevSAc2z-eZBN1bSFN7fDJi_5TluVNL0FZ_1kXCTK-d6qKfbUz0s8j_8x29tws4OrLHPn6w5c0fYuXHMFLH_cg8UcwfdXyTKq9bCsWtKHha1Z5o_eMGlL9vH7bDJjM4pMqtnCsrmjca0Z3f-yfcoC9PyUZTWbVySdF5pR9hBiUlYZhuCUTZwH6T6cTA9O9g-9rniDp0Q8brySa18LxFdKp8KPExnHkVBSRGXhl8IvNDeJFEaZJMSOMlBcFAKbFeIrU5bBAxjYyupHwAqpyDc4NmEkRRgXqSi1NDhwajhXkRjCq37b8qWj6MjRtKGly7eWbgi7_cbmnbTWOdp0aKUGaF0N4cW6GeWMnCfS6mpFfYgGCdEmDvHQnYP12wKRpEkc4JfEGydk3YE4vDdb7OJLy-WdkGOZ8yG87o_B78_66yQe_1Pv53B9Ppnms3fHR0_gBqeYnPYKaRcGzbeVfoqgqimedYLzC-kgFGA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Plasma+Apolipoproteins+A1%2FB+and+OxLDL+Levels+in+Patients+with+Covid-19+As+Possible+Markers+of+the+Disease&rft.jtitle=Cytology+and+genetics&rft.au=Pushkarev%2C+V.+V.&rft.au=Sokolova%2C+L.+K.&rft.au=Chervyakova%2C+S.+A.&rft.au=Belchina%2C+Yu.+B.&rft.date=2021-01-01&rft.pub=Pleiades+Publishing&rft.issn=0095-4527&rft.eissn=1934-9440&rft.volume=55&rft.issue=6&rft.spage=519&rft.epage=523&rft_id=info:doi/10.3103%2FS0095452721060116&rft.externalDocID=10_3103_S0095452721060116 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0095-4527&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0095-4527&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0095-4527&client=summon |